July 2002
A bulletin on major WHO Country and Regional work in the field of Essential Drugs and Medicines Policy
The purpose of
Essential drugs in brief
is to share information on
the latest country support
provided or coordinated
by the extended Drug
Action Programme team
(country, regional and
HQ offices).
It is an informal instrument
aiming to share our
experiences with colleagues
within and outside WHO,
who are active in the
implementation of national
drug policies at national
and regional levels.
Department of Essential Drugs
and Medicines Policy
Health Technology
and Pharmaceuticals Cluster
World Health Organization
|
The Department of Essential Drugs and Medicines Policy (EDM) is comprised of four teams:
Drug Action Programme (DAP); Policy, Access and Rational Use (PAR); Quality Assurance & Safety: Medicines (QSM); and Traditional Medicine (TRM).
Support to countries is provided in coordination with WHO Regional and Country Offices.
You may contact us by email: dap@who.int
tel: +41 22 791 4404; fax: +41 22 791 4167
World Health Organization
Essential Drugs and Medicines Policy, Drug Action Programme, Ave. Appia 20, 1211-Geneva-27, Switzerland
|
© World Health Organization, 2002
This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale for use in conjunction with commercial purposes.
The views expressed in documents by named authors are solely the responsibility of those authors.
Printed on paper made from pulp produced in managed softwood plantations where at least one tree is planted for every one cut down.
Printed in France
Loading...
